Abstract
A 74-year-old female with idiopathic myelofibrosis (IMF) was admitted to our hospital because of massive hematemesis and melena. Immediate upper gastrointestinal endoscopy revealed an intermittent spurting hemorrhage from extensive esophageal varices. Endoscopic injection sclerotherapy (EIS) was carried out and the bleeding ceased. After five courses of EIS, all the esophageal varices were eradicated. About 15 months later, the patient died,due to a cerebral hemorrhage, without further variceal bleeding. A postmortem examination was carried out and the portal hypertension was considered to be due not only to extramedullary hematopoiesis in the sinusoids, but also to increased splenic blood flow. We are confident that EIS is an effective therapeutic procedure for patients with IMF showing esophageal variceal hemorrhage. EIS should be the preferred choice of treatment for esophageal varices in patients with IMF, since it is less invasive than splenectomy.
Similar content being viewed by others
References
Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971;50: 357–420.
Nakai GS, Craddock CG, Figueroa WG. Agnogenic myeloid metaplasia. A survey of twenty-nine cases and a review of the literature. Ann Intern Med 1962;57:419–440.
Sullivan A, Rheinlander H, Weintraub LR. Esophageal varices in agnogenic myeloid dysplasia: Disappearance after splenectomy. Gastroenterology 1974;66:429–432.
Roux D, Merlio JP, Quinton A, et al. Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities. Gastroenterology 1987;92:1067–1072.
Dagradi AE, Siemsen J, Brook J, et al. Bleeding esophageal varices in myelofibrosis. Am J Gastroenterol 1965;44:536–544.
Silverstein MN, Gomes MR, Remie WH, et al. Agnogenic myeloid metaplasia. Natural history and treatment. Arch Intern Med 1967;120:546–550.
Fedeli G, Certo M, Cannizzaro O, et al. Etramedullary hematopoiesis involving the esophagus in myelofibrosis. Am J Gastroenterol 1990;85:1512–1514.
Block M, Jacobson LO. Myeloid metaplasia. JAMA. 1950;143: 1390–1396.
Benbassat J, Penchas S. “Early” splenectomy and survival in agnogenic myeloid metaplasia—an analysis of 338 cases published since 1940. Acta Haematol 1981;65:189–192.
Lopez-Guillermo A, Cervantes F, Bruguera M, et al. Liver dysfunction following splenectomy in idiopathic myelofibrosis: A study of 10 patients. Acta Haematol 1991;85:184–188.
Takase Y, Ozaki A, Orii K, et al. Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery. Surgery 1982;92:474–479.
Terblanche J, Northover JMA, Bornman P, et al. A prospective evaluation of injection sclerotherapy in the treatment of acute bleeding from esophageal varices. Surgery 1979;85:239–245.
Paquet KJ, Büsing V, Wobser E. Endoskopische befunde und therapietaktik bei osteomyelosklerose mit portaler hypertension und ösophagusvarizenblutung. Leber Magen Darm 1976;6: 358–360.
Jacobs P, Maze S, Tayob F, et al. Myelofibrosis, splenomegaly, and portal hypertension. Acta Haematol 1985;74:45–48.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takasaki, M., Takahashi, I., Takamatsu, M. et al. Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in a patient with idiopathic myelofibrosis. J Gastroenterol 31, 260–262 (1996). https://doi.org/10.1007/BF02389527
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02389527